BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu B, Chu Y, Hu Q, Song Q. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma. Technol Cancer Res Treat 2021;20:15330338211055340. [PMID: 34806493 DOI: 10.1177/15330338211055340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Ren H, Zhao L, Zhang X, Wang T, Sun C, Niu P, Wang W, Fei H, Guo C, Chen Y, Zhao D. Better Prognosis of Gastric Neuroendocrine Carcinoma Than Gastric Adenocarcinoma among Whites in the United States: A Propensity Score Matching Analysis Based on SEER. Current Oncology 2022;29:4879-4892. [DOI: 10.3390/curroncol29070387] [Reference Citation Analysis]
2 Zheng BH, Zhang C, Wan WZ, Sun WT, Cheng X, Ni XJ, Ni XL, Suo T, Liu H, Shen S, Liu HB. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database. BMC Surg 2022;22:253. [PMID: 35768809 DOI: 10.1186/s12893-022-01689-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chen G, Xu Q, Qian S, Wang Z, Wang S. Survival Analysis in Gastrointestinal Neuroendocrine Carcinoma With Bone Metastasis at Diagnosis. Front Surg 2022;9:820725. [DOI: 10.3389/fsurg.2022.820725] [Reference Citation Analysis]